![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0028.png)
27
27
Diretrizes AMB
(Antiphospholipid
Syndrome
OR
Anti-
Phospholipid
Antibody
Syndrome
OR
Antiphospholipid Antibody Syndrome OR Anti-
Phospholipid
Syndrome
OR
Antibodies,
Antiphospholipid) AND (Platelet Aggregation
Inhibitors OR Anticoagulants OR Coumarins OR
Heparin or Aspirin) AND (randomized controlled
trial[Publication
Type]
OR
(randomized[Title/Abstract]
AND
controlled[Title/Abstract]
AND
trial[Title/Abstract]) OR random*[Title/Abstract]
OR random allocation[mesh Terms])
PICO 2
A
ANTICOAGULAÇÃO POR TEMPO INDETERMINADO ESTÁ INDICADA EM
PACIENTES COM PASSADO DE TROMBOSE VENOSA E PRESENÇA DE
ANTICORPOS ANTIFOSFOLIPIDEOS
? Q
UAL DEVE SER O
INR
ALVO
?
(Antiphospholipid
Syndrome
OR
Anti-
Phospholipid
Antibody
Syndrome
OR
Antiphospholipid Antibody Syndrome OR Anti-
Phospholipid
Syndrome
OR
Antibodies,
Antiphospholipid) AND (Anticoagulants OR
Coumarins OR Heparin) AND Embolism and
Thrombosis AND ((clinical[Title/Abstract] AND
trial[Title/Abstract]) OR clinical trials[mesh Terms]
OR
clinical
trial[Publication
Type]
OR
random*[Title/Abstract]
OR
random